Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures.
The objective of this study was to determine the influence of lactose carrier size on drug dispersion of salmeterol xinafoate (SX) from interactive mixtures. SX dispersion was measured by using the fine particle fractions determined by a twin stage impinger attached to a Rotahaler. The particle size of the lactose carrier in the SX interactive mixtures was varied using a range of commercial inhalation-grade lactoses. In addition, differing size fractions of individual lactose samples were achieved by dry sieving. The dispersion of SX appeared to increase as the particle size of the lactose carrier decreased for the mixtures prepared from different particle size commercial samples of lactose and from different sieve fractions of the same lactose. Fine particles of lactose (<5 microm) associated with the lactose carrier were removed from the carrier surface by a wet decantation process to produce lactose samples with low but similar concentrations of fine lactose particles. The fine particle fractions of SX in mixtures prepared with the decanted lactose decreased significantly (analysis of variance, p < 0.001) and the degree of dispersion became independent of the volume mean diameter of the carriers (analysis of variance, p < 0.05). The dispersion behavior is therefore associated with the presence of fine adhered particles associated with the carriers and the inherent size of the carrier itself has little influence on dispersion.
Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville Vic 3052, Australia.
Nazrul
N
Islam
Peter
P
Stewart
Ian
I
Larson
Patrick
P
Hartley
D000280:Administration, Inhalation; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000737:chemistry*; D002214:Capsules; D002851:Chromatography, High Pressure Liquid; D004337:Drug Carriers; D007785:Lactose; D008956:Models, Chemical; D010316:Particle Size; D012044:Regression Analysis; D000068299:Salmeterol Xinafoate; D013056:Spectrophotometry, Ultraviolet
D001993:Bronchodilator Agents; D002214:Capsules; D004337:Drug Carriers; D000068299:Salmeterol Xinafoate; D007785:Lactose; D000420:Albuterol